Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


‘Stable’ Indian Pharma Outlook Seen Despite Challenges

This article was originally published in PharmAsia News

Executive Summary

One-year returns for investors in the Bombay Stock Exchange's Healthcare index may be down over 13%, but in what may bring some comfort to shareholders, the outlook for India’s pharmaceutical companies is "stable," according to an independent credit rating agency. This is despite a string of problems ranging from tighter US generic competition to intensifying regulatory scrutiny to emerging market currency volatility.



Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts